Form 10-Q Catalent, Inc. For: Sep 30

Go back to Form 10-Q Catalent, Inc. For: Sep 30

Catalent (CTLT) PT Lowered to $81 at Morgan Stanley But Sees Long-Term Entry Point

November 2, 2022 1:06 PM EDT

Morgan Stanley analyst Tejas Savant lowered the price target on Catalent (NYSE: CTLT) to $81.00 (from $120.00) while maintaining an Overweight rating following weak results, but says macro-driven reset provides an opportunity long-term entry point.

The analyst commented, "We lower sales/EBITDA... More